Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis.
Goodin DS, Biermann LD, Bohlega S, Boiko A, Chofflon M, Gebeily S, Gouider R, Havrdova E, Jakab G, Karabudak R, Karussis D, Miller A, Pakdaman H, Selmaj K, Sharief M; International Working Group for Treatment Optimization in MS.
Goodin DS, et al. Among authors: chofflon m.
Curr Med Res Opin. 2007 Nov;23(11):2823-32. doi: 10.1185/03007x233007.
Curr Med Res Opin. 2007.
PMID: 17908370
Review.